News
Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...
Graves' disease and thyroid eye disease (TED) - TSH antagonist Autosomal polycystic kidney disease (ADPKD) - SST3 agonist A live question-and-answer session will follow the formal presentations. To ...
The following is a summary of “Impact of Metformin on Plasma Prolactin Levels in Antipsychotics-Treated Men With ...
Song, Z. and Zhong, W. (2025) Research Advances in Subtype Classification and Diagnosis of Primary Aldosteronism. Journal of Biosciences and Medicines, 13, 1-11. doi: 10.4236/jbm.2025.136001 .
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified ...
Introduction: ACTH-dependent Cushing syndrome (CS) is a rare endocrine disease including Cushing disease (CD), ectopic ACTH syndrome (EAS) and ectopic corticotropin-releasing hormone (CRH) syndrome.
Adrenocorticotrophin (ACTH) is the major regulatory hormone of steroid synthesis and secretion by adrenocortical cells. The actions of ACTH are mediated by its specific membrane receptor (ACTH-R). The ...
The sweet smile on Siena Hale’s pretty face melts the hearts of those she encounters. Her inquisitive eyes quickly scan the ...
Results: Results are available in a week. Please contact your doctor if you are not called about the result. Adrenocorticotropic Hormone (ACTH) Stimulation Test for Non-classic Congenital Adrenal ...
The use of ACTH preparations in SLE is supported by over 60 years of clinical experience,12 and a more recent open-label, single-arm case series involving 10 patients with chronic moderate-to-severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results